Medical aesthetics company Sientra Inc announces it has entered into a services agreement with Vesta, a Lubrizol LifeSciences company.

Sientra’s announcement is part of its progress toward establishing a long-term manufacturing solution for its breast implant products, according to a media release from the Santa Barbara, Calif-based company.

Franklin, Wis-based Vesta Intermediate Funding Inc is a medical device contract manufacturer of silicone products and other medical devices.

Under terms of the agreement, Vesta is establishing manufacturing capacity for Sientra and is working with the company to finalize a long-term supply arrangement for its PMA-approved breast implants. Sientra anticipates that all project milestones will be achieved for the Company to submit a PMA Supplement to the FDA during the first quarter of 2017, the release notes.

“Our relationship with Vesta is an important component of our comprehensive manufacturing plan. Vesta is an established manufacturer with proven capabilities in producing implantable silicone medical devices and components with a strong reputation for quality and safety. We have already made significant progress with Vesta, and we are confident that this ongoing relationship will enable us to uphold our promise to board-certified plastic surgeons to maintain an uninterrupted supply of our breast implant products,” says Sientra Chairman and CEO Jeffrey M. Nugent, in the release.

[Source: Sientra Inc]